Effects of Blocking Individual Maturation Cleavages in Murine Leukemia Virus Gag
Open Access
- 1 February 2004
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (3) , 1411-1420
- https://doi.org/10.1128/jvi.78.3.1411-1420.2004
Abstract
A single protein, termed Gag, is responsible for retrovirus particle assembly. After the assembled virion is released from the cell, Gag is cleaved at several sites by the viral protease (PR). The cleavages catalyzed by PR bring about a wide variety of physical changes in the particle, collectively termed maturation, and convert the particle into an infectious virion. In murine leukemia virus (MLV) maturation, Gag is cleaved at three sites, resulting in formation of the matrix (MA), p12, capsid (CA), and nucleocapsid (NC) proteins. We introduced mutations into MLV that inhibited cleavage at individual sites in Gag. All mutants had lost the intensely staining ring characteristic of immature particles; thus, no single cleavage event is required for this feature of maturation. Mutant virions in which MA was not cleaved from p12 were still infectious, with a specific infectivity only ∼10-fold below that of the wild type. Particles in which p12 and CA could not be separated from each other were noninfectious and lacked a well-delineated core despite the presence of dense material in their interiors. In both of these mutants, the dimeric viral RNA had undergone the stabilization normally associated with maturation, suggesting that this change may depend upon the separation of CA from NC. Alteration of the C-terminal end of CA blocked CA-NC cleavage but also reduced the efficiency of particle formation and, in some cases, severely disrupted the ability of Gag to assemble into regular structures. This observation highlights the critical role of this region of Gag in assembly.Keywords
This publication has 35 references indexed in Scilit:
- Charged Assembly Helix Motif in Murine Leukemia Virus Capsid: an Important Region for Virus Assembly and Particle Size DeterminationJournal of Virology, 2003
- Defects in Virion Production Caused by Mutations Affecting the C-Terminal Portion of the Moloney Murine Leukemia Virus Capsid ProteinJournal of Virology, 2003
- Murine Leukemia Virus Nucleocapsid Mutant Particles Lacking Viral RNA Encapsidate RibosomesJournal of Virology, 2002
- Reversal by Dithiothreitol Treatment of the Block in Murine Leukemia Virus Maturation Induced by Disulfide Cross-LinkingJournal of Virology, 2002
- Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyproteinNature Structural & Molecular Biology, 2002
- Human Immunodeficiency Virus Type 1 N-Terminal Capsid Mutants That Exhibit Aberrant Core Morphology and Are Blocked in Initiation of Reverse Transcription in Infected CellsJournal of Virology, 2001
- Proteolytic Processing of the P2/Nucleocapsid Cleavage Site Is Critical for Human Immunodeficiency Virus Type 1 RNA Dimer MaturationJournal of Virology, 2001
- Green Fluorescent Protein as a Selectable Marker of Fibronectin-Facilitated Retroviral Gene Transfer in Primary Human T LymphocytesHuman Gene Therapy, 1999
- Characterization of rauscher leukemia virus (RLV) P40–42, an intermediate cleavage product of the group specific antigen (gag) precursor polypeptide, P65–70Biochemical and Biophysical Research Communications, 1977
- Properties of a P70 proteolytic factor of murine leukemia virusesCell, 1977